Beryl Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Beryl Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-473,492	Closed	-$4.74M	–	36
2022 Q3	$4.74M	Buy	+473,492	New	+$4.71M	0.5%	19
2022 Q2	–	Sell	-493,618	Closed	-$4.87M	–	262
2022 Q1	$4.87M	Sell	493,618 -900,000	-65%	-$8.84M	0.3%	142
2021 Q4	$13.7M	Buy	1,393,618 +500,000	+56%	+$4.93M	0.71%	25
2021 Q3	$8.77M	Buy	893,618 +237,999	+36%	+$2.34M	0.62%	52
2021 Q2	$6.48M	Buy	655,619 +328,888	+101%	+$3.31M	0.58%	52
2021 Q1	$3.36M	Buy	+326,731	New	+$3.63M	0.43%	78

Beryl Capital Management's LUXA Position: Q4 2022 in Review

Beryl Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 473,492 shares — an estimated $4.74M sold.

Beryl Capital Management first reported a position in LUXA in Q1 2021 and held it in 6 quarters. The position peaked at $13.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Beryl Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Beryl Capital Management sold 473,492 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $4.74M.
Beryl Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 6 quarters.
Beryl Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $13.7M in Q4 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Beryl Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.